ŌGI Bio

ŌGI Bio is a private, early-revenue synthetic biology tools company offering an automated, modular bioreactor system for microbial culture. The company's technology, the OGI3 Bioreactor, automates labor-intensive culturing processes at the bench scale, generating transferable data to bridge the gap between small-scale discovery and larger-scale applications. Targeting academic and industrial R&D labs, ŌGI Bio's value proposition centers on saving scientist time, increasing experimental throughput, and improving data quality. The company appears to be in a growth phase, building its team and product capabilities based in London and Edinburgh.

The OGI3 is a modular, automated, bench-top bioreactor system with WiFi-enabled software for remote monitoring and control. It automates microbial culture (bacteria, yeast, algae, phage) at 14-20ml scales, replacing manual shake-flask methods to generate high-quality, scalable data for R&D.

ŌGI Bio competes in the bench-scale bioreactor and lab automation space. Key competitors include large instrument companies like Sartorius (Ambr® systems), Thermo Fisher, and Eppendorf, as well as smaller startups. ŌGI's differentiation lies in its focus on modularity, software-enabled remote access, and avoiding single-use consumables for the 14-20ml scale niche.